Clinical trial • Phase III • Musculoskeletal|Immunology
surovatamig for Rheumatoid arthritis|Systemic lupus erythematosus
Phase III trial of surovatamig for Rheumatoid arthritis|Systemic lupus erythematosus. 33 participants.
Overview
- Trial Therapeutic Area
- Musculoskeletal|Immunology
- Trial Disease
- Rheumatoid arthritis|Systemic lupus erythematosus
- Trial Stage
- Phase III
Key dates
- Initial CTIS Submission Date
- 15-10-2025
- First CTIS Authorization Date
- 03-02-2026
Trial design
Phase III trial across 11 sites in Belgium, Germany, Spain.
- Target Sample Size
- 33
Eligibility
Recruits 33 Vulnerable populations selected; no details on consent or assent handling available in source..
- Vulnerable Population
- Vulnerable populations selected; no details on consent or assent handling available in source.
Recruitment
- Planned Sample Size
- 33
- Recruitment Window Months
- 27
Geography
- Total Number Of Sites
- 11
- Total Number Of Participants
- 15
Belgium
- Earliest CTIS Part Ii Submission Date
- 20-01-2026
- Latest Decision Or Authorization Date
- 09-02-2026
- Processing Time Days
- 20
- Number Of Sites
- 4
- Number Of Participants
- 5
Sites
- Site Name
- Centre hospitalier universitaire de Liege
- Department Name
- Department of rheumatology
- Principal Investigator Name
- Clio Ribbens
- Principal Investigator Email
- Clio.Ribbens@chuliege.be
- Contact Person Name
- Clio Ribbens
- Contact Person Email
- Clio.Ribbens@chuliege.be
- Site Name
- Universitair Ziekenhuis Antwerpen
- Department Name
- Department of immunology, allergology and rheumatology
- Principal Investigator Name
- Margot Van Mechelen
- Principal Investigator Email
- margot.vanmechelen@uza.be
- Contact Person Name
- Margot Van Mechelen
- Contact Person Email
- margot.vanmechelen@uza.be
- Site Name
- Ziekenhuis Aan De Stroom
- Department Name
- Department of rheumatology
- Principal Investigator Name
- Alla Ishchenko
- Principal Investigator Email
- alla.ishchenko@zas.be
- Contact Person Name
- Alla Ishchenko
- Contact Person Email
- alla.ishchenko@zas.be
- Site Name
- Ziekenhuis Aan De Stroom
- Department Name
- Department of rheumatology
- Principal Investigator Name
- Alla Ishchenko
- Principal Investigator Email
- alla.ishchenko@zas.be
- Contact Person Name
- Alla Ishchenko
- Contact Person Email
- alla.ishchenko@zas.be
Germany
- Earliest CTIS Part Ii Submission Date
- 02-02-2026
- Latest Decision Or Authorization Date
- 03-02-2026
- Processing Time Days
- 1
- Number Of Sites
- 4
- Number Of Participants
- 5
Sites
- Site Name
- LMU Klinikum Muenchen AöR
- Department Name
- Medizinische Klinik und Poliklinik IV Sektion Rheumatologie und klinische Immunologie–Studienambu
- Principal Investigator Name
- Hendrik Schulze-Koops
- Principal Investigator Email
- Hendrik.Schulze-Koops@med.uni-muenchen.de
- Contact Person Name
- Hendrik Schulze-Koops
- Contact Person Email
- Hendrik.Schulze-Koops@med.uni-muenchen.de
- Site Name
- Universitaetsklinikum Jena KöR
- Department Name
- Klinik für Innere Medizin III Rheumazentrum (G-BA-Kriterien) sowie Sektion Rheumatologie und Osteol
- Principal Investigator Name
- Alexander Pfeil
- Principal Investigator Email
- alexander.pfeil@med.uni-jena.de
- Contact Person Name
- Alexander Pfeil
- Contact Person Email
- alexander.pfeil@med.uni-jena.de
- Site Name
- Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR
- Department Name
- Med. Klinik und Poliklinik Nephrology
- Principal Investigator Name
- Julia Weinmann-Menke
- Principal Investigator Email
- julia.weinmann-menke@unimedizin-mainz.de
- Contact Person Name
- Julia Weinmann-Menke
- Contact Person Email
- julia.weinmann-menke@unimedizin-mainz.de
- Site Name
- Universitaetsklinikum Bonn AöR
- Department Name
- Rheumatology
- Principal Investigator Name
- Valentin Schäfer
- Principal Investigator Email
- Valentin.Schaefer@ukbonn.de
- Contact Person Name
- Valentin Schäfer
- Contact Person Email
- Valentin.Schaefer@ukbonn.de
Spain
- Earliest CTIS Part Ii Submission Date
- 29-10-2025
- Latest Decision Or Authorization Date
- 06-02-2026
- Processing Time Days
- 100
- Number Of Sites
- 3
- Number Of Participants
- 5
Sites
- Site Name
- Hospital De La Santa Creu I Sant Pau
- Department Name
- Rheumatology
- Principal Investigator Name
- Hye Sang Park
- Principal Investigator Email
- hsang@santpau.cat
- Contact Person Name
- Hye Sang Park
- Contact Person Email
- hsang@santpau.cat
- Site Name
- Hospital Universitario Ramon Y Cajal
- Department Name
- Rheumatology
- Principal Investigator Name
- Francisco Javier Bachiller Corral
- Principal Investigator Email
- fbachiller@salud.madrid.org
- Contact Person Name
- Francisco Javier Bachiller Corral
- Contact Person Email
- fbachiller@salud.madrid.org
- Site Name
- Hospital Universitario Reina Sofia
- Department Name
- Rheumatology
- Principal Investigator Name
- Alejandro Escudero Contreras
- Principal Investigator Email
- alexcudero@hotmail.com
- Contact Person Name
- Alejandro Escudero Contreras
- Contact Person Email
- alexcudero@hotmail.com
Sponsor
Primary sponsor
- Full Name
- AstraZeneca AB
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- Sweden
Investigational products
- Investigational Product Name
- surovatamig
Related trials
Other published trials that may interest you.
- KYV-101 for Lupus nephritis|Systemic sclerosis|Myasthenia gravis|Rheumatoid arthritis|Stiff-person syndrome
- Ixekizumab for Psoriatic arthritis
- RITUXIMAB for Systemic sclerosis
- anakinra for Systemic juvenile idiopathic arthritis (sJIA) | Still's disease
- DAZUKIBART for Idiopathic inflammatory myopathy|Dermatomyositis|Polymyositis